An Open-Label, Multicenter Clinical Trial With Nivolumab (BMS-936558) Monotherapy in Subjects With Advanced or Metastatic Squamous Cell (Sq) Non-Small Cell Lung Cancer (NSCLC) Who Have Received at Least One Prior Systemic Regimen for the Treatment of Stage IIIb/IV SqNSCLC (Checkmate 171)
Sponsor: Bristol-Myers Squibb
Listed as NCT02409368, this PHASE2 trial focuses on Non-Small Cell Lung Cancer and remains completed. Sponsored by Bristol-Myers Squibb, it has been updated 22 times since 2015, reflecting substantial change activity. This study contributes to the evolving evidence base for cancer treatment protocols.
Status Flow
Change History
22 versions recorded-
Sep 2025 — Present [monthly]
Completed PHASE2
-
Jun 2025 — Sep 2025 [monthly]
Completed PHASE2
-
Oct 2024 — Jun 2025 [monthly]
Completed PHASE2
-
Sep 2024 — Oct 2024 [monthly]
Completed PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE2
▶ Show 17 earlier versions
-
Dec 2022 — Jul 2024 [monthly]
Completed PHASE2
-
Jan 2022 — Dec 2022 [monthly]
Completed PHASE2
-
Nov 2021 — Jan 2022 [monthly]
Completed PHASE2
Status: Active Not Recruiting → Completed
-
Sep 2021 — Nov 2021 [monthly]
Active Not Recruiting PHASE2
-
Jan 2021 — Sep 2021 [monthly]
Active Not Recruiting PHASE2
-
Jul 2020 — Jan 2021 [monthly]
Active Not Recruiting PHASE2
-
Nov 2019 — Jul 2020 [monthly]
Active Not Recruiting PHASE2
-
Nov 2018 — Nov 2019 [monthly]
Active Not Recruiting PHASE2
-
Jun 2018 — Nov 2018 [monthly]
Active Not Recruiting PHASE2
-
Dec 2017 — Jun 2018 [monthly]
Active Not Recruiting PHASE2
-
Nov 2017 — Dec 2017 [monthly]
Active Not Recruiting PHASE2
-
Sep 2017 — Nov 2017 [monthly]
Active Not Recruiting PHASE2
-
Aug 2017 — Sep 2017 [monthly]
Active Not Recruiting PHASE2
-
Jul 2017 — Aug 2017 [monthly]
Active Not Recruiting PHASE2
-
May 2017 — Jul 2017 [monthly]
Active Not Recruiting PHASE2
-
Feb 2017 — May 2017 [monthly]
Active Not Recruiting PHASE2
-
Jan 2017 — Feb 2017 [monthly]
Active Not Recruiting PHASE2
First recorded
Apr 2015
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Bristol-Myers Squibb
- PPD Development, LP
For direct contact, visit the study record on ClinicalTrials.gov .